Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2020 | Circulating microRNAs as MRD biomarkers in pediatric ALL

Dániel János Erdélyi • 29 Jun 2020
ESH AL 2020
Acute Lymphoblastic Leukemia Leukemia Cytarabine Methotrexate

Dániel János Erdélyi, PhD, Semmelweis University, Budapest, Hungary, discusses the role of circulating microRNAs as minimal residual disease (MRD) biomarkers in childhood acute lymphoblastic leukemia (ALL). Compared to the current practice of MRD monitoring, this approach would have the advantage of less invasive sampling and no need for general anesthesia. Although microRNAs were less sensitive than current standards of patient follow-up, Dr János Erdélyi reveals that they could be used as tools to monitor CNS disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Dániel János Erdélyi

MicroRNA-181a: a novel marker of CNS involvement in pediatric ALL
2:03
MicroRNA-181a: a novel marker of CNS involvement in pediatric ALL
Dániel János Erdélyi • 29 Jun 2020

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals